BRCA1 and cancer: Among the individuals with a pathogenic finding, 43.6% (126/289) of the alterations identified cases, the alteration identified occurred in the BRCA1 or BRCA2 genes, indicating the significant contribution of these two genes in hereditary cancer predisposition.